The first detailed study of infection of nonhuman primates with the retrovirus XMRV reveals that the virus establishes a persistent infection characterized by infection of multiple tissues. Viremia (virus in the blood) is low and transient, with proviral DNA detectable in blood lymphocytes. The results show that the Rhesus macaque can be used to study …
Hosts: Vincent Racaniello, Rich Condit, and Ed Niles On episode #120 of the podcast This Week in Virology, Vincent, Rich, and Ed discuss the transition from academic scientist to government work, the general program of drug and vaccine development in the biodefense world and at BARDA, and career opportunities for scientists in government. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV120.mp3″] Click the …
A type of human encephalitis – an infection of the brain – has been known to affect the indigenous people living in the Sakha Republic of Russia since the mid-1800s. The available clinical and epidemiological evidence suggests that the disease is caused by a pathogen, but proving this has been difficult. The disease is called …
Hosts: Vincent Racaniello and David Tuller On episode #119 of the podcast This Week in Virology, Vincent and journalist David Tuller converse about the state of science reporting by the press. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV119.mp3″] Click the arrow above to play, or right-click to download TWiV #119 (43 MB .mp3, 60 minutes). Subscribe to TWiV (free) in iTunes , …
TWiV 119: Science and journalism with David Tuller Read More »
Excellent description by Jonah Lehrer in “The Truth Wears Off” (The New Yorker) on the importance of confirming experimental findings in different laboratories: Before the effectiveness of a drug can be confirmed, it must be tested and tested again. Different scientists in different labs need to repeat the protocols and publish their results. The test …
Frederick Hayden, Professor of Medicine and Pathology, University of Virginia School of Medicine, U.K., has focused on the use of antiviral agents to prevent and treat respiratory viral infections. His interests range from the use of in vitro assays to study viral susceptibility and antiviral mechanisms of action, to clinical trials utilizing experimentally induced and …
